Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-01-04
2005-01-04
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S275000, C544S324000, C544S325000, C544S317000, C544S326000, C544S327000, C544S328000, C544S329000
Reexamination Certificate
active
06838464
ABSTRACT:
Pyrimidine derivatives of formula (I) wherein Q1, Q2, G and R1are as defined within; and pharmaceutically acceptable salts and in vivo hydrolysable esters thereof are described. Processes for their manufacture, pharmaceutical compositions and their use as cyclin-dependent serine/threonine kinase (CDK) and focal adhesion kinase (FAK) inhibitors are also described.
REFERENCES:
patent: 4983608 (1991-01-01), Effland et al.
patent: 5516775 (1996-05-01), Zimmermann et al.
patent: 5521184 (1996-05-01), Zimmermann
patent: 5610303 (1997-03-01), Kimura et al.
patent: 5739143 (1998-04-01), Adams et al.
patent: 5859041 (1999-01-01), Liverton et al.
patent: 6593326 (2003-07-01), Bradbury et al.
patent: 2231765 (1998-09-01), None
patent: 0 363 002 (1990-04-01), None
patent: 0 379 806 (1990-08-01), None
patent: 0 564 409 (1993-10-01), None
patent: 0 945 443 (1999-09-01), None
patent: 9118887 (1991-12-01), None
patent: 9220642 (1992-11-01), None
patent: 9509847 (1995-04-01), None
patent: 9509851 (1995-04-01), None
patent: 9509852 (1995-04-01), None
patent: 9509853 (1995-04-01), None
patent: 9515952 (1995-06-01), None
patent: 9605177 (1996-02-01), None
patent: 9628427 (1996-09-01), None
patent: 9640143 (1996-12-01), None
patent: 9719065 (1997-05-01), None
patent: 9735856 (1997-10-01), None
patent: 9740017 (1997-10-01), None
patent: 9744326 (1997-11-01), None
patent: 9747618 (1997-12-01), None
patent: 9811095 (1998-03-01), None
patent: 9816230 (1998-04-01), None
patent: 9818782 (1998-05-01), None
patent: 9825619 (1998-06-01), None
patent: 9833798 (1998-08-01), None
patent: 9841512 (1998-09-01), None
patent: 9854093 (1998-12-01), None
patent: 9856788 (1998-12-01), None
patent: 9901136 (1999-01-01), None
patent: 9932121 (1999-01-01), None
patent: 9918096 (1999-04-01), None
patent: 9918942 (1999-04-01), None
patent: 9931073 (1999-06-01), None
patent: 9941253 (1999-08-01), None
patent: 9950250 (1999-10-01), None
patent: WO 0012485 (2000-03-01), None
patent: 0012485 (2000-03-01), None
patent: WO 0012486 (2000-03-01), None
patent: 0012486 (2000-03-01), None
patent: 0017202 (2000-03-01), None
patent: 0017203 (2000-03-01), None
patent: 0021926 (2000-04-01), None
patent: 0025780 (2000-05-01), None
patent: 0026209 (2000-05-01), None
patent: 0039101 (2000-07-01), None
patent: WO 0039101 (2000-07-01), None
patent: 0044750 (2000-08-01), None
patent: 0049018 (2000-08-01), None
patent: WO 0053595 (2000-09-01), None
patent: 0053595 (2000-09-01), None
patent: 0055161 (2000-09-01), None
patent: 0059892 (2000-10-01), None
patent: WO 0059892 (2000-10-01), None
patent: 0078731 (2000-12-01), None
patent: 0114375 (2001-03-01), None
patent: WO 0114375 (2001-03-01), None
patent: 0129009 (2001-04-01), None
patent: 0130778 (2001-05-01), None
patent: 0137835 (2001-05-01), None
patent: 0147897 (2001-07-01), None
patent: 0147921 (2001-07-01), None
patent: 0160816 (2001-08-01), None
patent: 0164653 (2001-09-01), None
patent: WO 0164653 (2001-09-01), None
patent: WO 0164654 (2001-09-01), None
patent: 0164654 (2001-09-01), None
patent: 0164655 (2001-09-01), None
patent: WO 0164655 (2001-09-01), None
patent: 0172717 (2001-10-01), None
patent: WO 0172717 (2001-10-01), None
patent: WO 0104429 (2002-01-01), None
patent: 0204429 (2002-01-01), None
patent: 0220512 (2002-03-01), None
Bennett, Cecil Textbook of Medicine, 20th edition, vol. 1, 1004-1010, 1997.*
Kornberg, Head Neck 20(8): 745-52, 1998.*
U.S. patent application Ser. No. 09/763,681, Breault et al., filed Feb. 26, 2001.
U.S. patent application Ser. No. 09/763,705, Breault et al., filed Feb. 26, 2001.
U.S. patent application Ser. No. 09/868,602, Bradbury et al., filed Jun. 20, 2001.
U.S. patent application Ser. No. 09/914,788, Breault et al., filed Sep. 5, 2001.
U.S. patent application Ser. No. 09/958,077, Breault, filed Oct. 4, 2001.
U.S. patent application Ser. No. 10,220,139, Pease et al., filed Aug. 28, 2002.
U.S. patent application Ser. No. 10/069,019, Thomas et al., filed Feb. 21, 2002.
U.S. patent application Ser. No. 10/203,154, Pease et al., filed Aug. 6, 2002.
U.S. patent application Ser. No. 10/203,549, Pease et al., filed Aug. 8, 2002.
U.S. patent application Ser. No. 10/239,790, Thomas et al., filed Sep. 25, 2002.
U.S. patent application Ser. No. 10/332,275, Thomas et al., filed Jan. 7, 2003.
Boschelli et al., Synthesis and Tyrosine Kinase Inhibitory Activity of a Series of 2-Amino-8-H-pyrido[2,3-d]pyrimidines: Identifidation of Potent, Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitors, J. Med. Chem., vol. 41, 1998, pp. 4365-4377.
Deady et al., “Reactions of some Quinazoline Compounds with Ethoxymethylenemalonic Acid Derivatives”, J. Heterocyclic Chem., vol. 26, 1989, pp. 161-168.
Donnellan et al., “Cyclin E in human cancers”, FASEB Journal, 13, 1999, pp. 773-780.
El-Kerdawy et al.; “2,4-Bis (Substituted)-5-Nitropyrimidines of Expected Diuretic Action”; Egypt J. Chem. vol. 29, No. 2, 1986, pp. 247-251.
Fiziol Akt Veshchestva, 1975, vol. 7, pp. 68-72.
Ghosh et al.; “2,4-Bis(arylamino)-5-methylpyrimidines as Antimicrobial Agents”; J. Med. Chem., 1967, vol. 10, No. 5, pp. 974-975.
Ghosh, “2,4-Bis(Arylamino)-6-Methyl Pyrimidines as Antimicrobial Agents”, J. Indian Chem. Soc., vol. 58, No. 5, 1981, pp. 512-513.
Ghosh, “2,4-Bis(arylamino)-6-methylpyrimidines as an antimicrobial agents”, Chemical Abstract No. 97712f, vol. 95, 1981, pp. 648.
Schmidt et al.; “A Convenient Synthesis of 2-substituted 4-Amino-5-pyrimidinecarbonitriles”; J. Heterocycle Chem., 1997, vol. 24, No. 5, pp. 1305-1307.
Zimmermann et al., Phenylamino-Pyrimidine (PAP) Derivatives: A New Class of Potent and Slective Inhibitors of Protein Kinase C (PKC), Arch. Pharm. Pharm. Med. Chem., vol. 329, 1996, pp. 371-376.
Bradbury Robert Hugh
Pearson Stuart Eric
Pease Elizabeth Janet
Williams Emma Jane
AstraZeneca AB
Balasubramanian Venkataraman
Morgan & Lewis & Bockius, LLP
LandOfFree
2,4-Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,4-Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,4-Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3417754